____________________________________Neuvax for those starting their DD______________________________________- (1) - U.S. Department of Defense (Military’s Groundbreaking Vaccine Targets Breast Cancer): http://www.defense.gov/news/newsarticle.aspx?id=66697- (2) - FORBES article (Roche Accelerates Defense Strategy to Protect Breast-Cancer Drug Herceptin's Turf): http://www.forbes.com/sites/genemarcial/2012/03/15/roche-accelerates-defense-strategy-to-protect-breast-cancer-drug-herceptins-turf/?partner=yahoofeed- (3) - Galena Biopharma Strengthens NeuVax(TM) Intellectual Property Position With Notice of Allowance for U.S. Patent: http://finance.yahoo.com/news/galena-biopharma-strengthens-neuvax-tm-110500442.html- (4) - NeuVax is produced for less than $1,000 per dose, which reflects the potential for very large margins considering Dendreon's (DNDN) Provenge which has an off-the-shelf product being produced for roughly $20,000: http://seekingalpha.com/article/448501-galena-biopharma-s-patent-creates-both-immediate-and-long-term-upside?source=yahoo- (5) - Truht about Morhamus article: http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_G/threadview?m=te&bn=78354&tid=35312&mid=35312&tof=63&frt=2#35312 - (6) - Army doctor develops breast cancer vaccine: http://www.armytimes.com/news/2012/02/army-vaccine-trial-breast-cancer-patients-021312w/- (7) - Clinical Trial Info: www.neuvax.com- (8) - Galena Biopharma and CytRx Corp Look to Benefit From Accelerated Approval Pathways: http://finance.yahoo.com/news/galena-biopharma-cytrx-corp-look-122000858.html
Thank you kindly for sharing these factual and solid reports on NeuVax and Gale.Nothing beats good and solid DD before making any investment and Gale is no exception.Unfortunate, their are far too many lazy "specultators" out there who wants to make a fast buck.When they want to buy, they try to bash the stock with the hope that its price will move down.When they bought the shares of a stock speculatively, they dream up reasons to cheer that stock with the hope of push its price up and make some fast money.There are just too many of these "stock market hyeanas" who create so much disruption and prevent the market's normal and healthy function.
1.90 bump :)
Thanks for the links. The Morhamus article is interesting and may have a valid point or two, but there are many legitimate positive things about the company.
no problem :)
=> together the financing research from Roche, Gennentech
=> SPA=> FAST TRACK=> OWN PATENT=> NO DEBT=> secured funding for two years in advance=> The cooperation with the army (the army is involved in research)=> 10 years of research as well as experience=> 0% recurrence